Souhaitez-vous accéder aux communiqués récents ?

WASHINGTON, DC, May 17, 2026 (GLOBE NEWSWIRE) -- Research presented at the American Urological Association (AUA) Annual Meeting in Washington, DC, highlights how commonly used medications may...

Informational overview of MEDVi QUAD's compounded ED prescription model, FDA framework, telehealth structure, and enrollment considerations.

MEDVI Quad prescription information updated as consumer interest in prescription erectile dysfunction treatment access through telehealth grows

Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health...

LAUSANNE, Switzerland, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Comphya SA, a clinical-stage MedTech company pioneering the first implantable neurostimulation therapy for erectile dysfunction (ED)...

- IDE approval obtained; U.S. pilot study clinical site launched at Johns Hopkins- Series B round in planning to support pivotal U.S. trial- New CEO appointment signals next phase of growth and...

Dallas, TX, May 27, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health and...

Phoenix, May 03, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why more men are turning to at-home ED treatment solutions over traditional medications and surgeriesThe science behind...

New York City, April 19, 2025 (GLOBE NEWSWIRE) -- Understanding the Male Performance Crisis in 2025 Why So Many Men Are Struggling Right Now Across the world, millions of men are silently...

New York City, April 08, 2025 (GLOBE NEWSWIRE) -- Erectile dysfunction (ED) is a common issue that affects millions of men worldwide, leading to frustration, anxiety, and relationship challenges....